Vignette-Based Economic Models in NICE Submissions: A Two-Year Review

Previous PostThe Cost-Effectiveness of Immunotherapies for Advanced Biliary Tract Carcinoma: A PRISMA Systematic Literature Review
Next PostThe importance of rare disease-specific procedures in HTA processes in ensuring equitable access to orphan products as a result of EU JCA